Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Operating Income Growth
23.80%
TTM · Period ending:
LCTX Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported23.80%period ending
Latest reported23.80%period ending
LCTX TTM Operating Income YoY % (-20.00% → 23.80%)
Year-over-year change
High-resolution chart · PNG
LCTX operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 32.4086% | |
| 25.3324% | |
| 10.0612% | |
| -2.0306% | |
| -71.6833% | |
| -60.131% | |
| -38.4615% | |
| 0% | |
| 9.3023% | |
| -11.4286% | |
| -26.6667% | |
| -10.2564% | |
| -9.0909% | |
| -40% | |
| -42.8571% | |
| -387.5% | |
| -135.7143% | |
| -19.0476% | |
| 8.6957% | |
| 61.9048% | |
| 22.2222% | |
| -40% | |
| -64.2857% | |
| -75% | |
| -50% | |
| -25% | |
| -27.2727% | |
| -9.0909% | |
| -20% |